Jazz Pharmaceuticals (JAZZ)
124.25
1.33 (1.08%)
At close: Mar 31, 2025, 3:59 PM
124.80
0.45%
After-hours: Mar 31, 2025, 07:58 PM EDT
Jazz Pharmaceuticals Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 |
| Cash & Equivalents | 2.41B | 1.51B | 881.48M | 591.45M | 1.06B | 637.34M | 309.62M | 386.04M | 365.96M | 988.78M | 684.04M | 636.5M | 387.2M | 82.08M | 44.79M | 15.6M | 24.9M | 102.94M | 78.95M | 20.61M |
| Short-Term Investments | 580M | 120M | 30M | n/a | 1.07B | 440M | 515M | 215M | 60M | n/a | n/a | n/a | n/a | 75.82M | n/a | n/a | 1M | 12M | n/a | n/a |
| Long-Term Investments | n/a | 4.7M | 5.5M | 12.03M | 5.24M | 7.43M | 9.59M | 7.67M | 9.74M | 23.27M | 33.17M | 14.61M | 16.58M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 123.97M | 69.24M | 58.89M | 40.81M | 25.72M | 47.91M | 42.7M | 16.42M | 14.06M | 27.55M | 15.93M | 7.3M | 3.66M | 87K | 335K | 1.25M | 246K | 13.27M | 13.55M | 13.83M |
| Receivables | 716.76M | 705.79M | 651.49M | 563.36M | 396.49M | 355.99M | 263.84M | 224.13M | 234.24M | 209.69M | 186.37M | 124.81M | 75.48M | 34.37M | 22.08M | 12.31M | 6.64M | 5.39M | 5.38M | 3.6M |
| Inventory | 480.44M | 597.04M | 714.06M | 1.07B | 95.4M | 78.61M | 52.96M | 43.24M | 34.05M | 19.45M | 30.04M | 28.67M | 26.52M | 3.91M | 5.05M | 3.43M | 4.79M | 2.21M | 3.03M | 3.26M |
| Other Current Assets | 438.95M | 506.29M | 359.1M | 383.81M | 214.91M | 118.33M | 92.59M | 99.87M | 53.81M | 39.75M | 115.39M | 74.64M | 62.37M | 2.95M | 2.54M | 5.62M | 7.16M | 3.6M | 3.93M | 3.61M |
| Total Current Assets | 4.63B | 3.44B | 2.61B | 2.61B | 2.84B | 1.63B | 1.23B | 968.28M | 748.07M | 1.26B | 1.02B | 864.62M | 551.57M | 199.13M | 74.46M | 36.95M | 44M | 116.09M | 91.56M | 31.38M |
| Property-Plant & Equipment | 227M | 234.99M | 301.38M | 343.42M | 257.1M | 270.89M | 200.36M | 170.08M | 107.49M | 85.57M | 58.36M | 14.25M | 7.28M | 1.56M | 690K | 1.12M | 2.51M | 3.94M | 2.11M | 1.94M |
| Goodwill & Intangibles | 6.47B | 7.17B | 7.49B | 8.98B | 3.15B | 3.36B | 3.66B | 3.93B | 3.91B | 1.84B | 2.14B | 1.26B | 1.31B | 52.8M | 60.25M | 68.07M | 70.74M | 74.25M | 107.35M | 117.62M |
| Total Long-Term Assets | 7.38B | 7.96B | 8.23B | 9.69B | 3.7B | 3.91B | 3.97B | 4.16B | 4.05B | 2.1B | 2.32B | 1.37B | 1.41B | 54.44M | 61.27M | 70.44M | 73.5M | 91.46M | 123.01M | 133.4M |
| Total Assets | 12.01B | 11.39B | 10.84B | 12.3B | 6.54B | 5.54B | 5.2B | 5.12B | 4.8B | 3.36B | 3.34B | 2.24B | 1.97B | 253.57M | 135.73M | 107.4M | 117.5M | 207.55M | 214.57M | 164.78M |
| Account Payables | 77.87M | 102.75M | 90.76M | 100.3M | 26.95M | 47.55M | 40.6M | 24.37M | 22.41M | 21.81M | 25.13M | 21M | 15.89M | 5.13M | 3.05M | 2.16M | 5.74M | 2.86M | 5.44M | 4.79M |
| Deferred Revenue | n/a | n/a | 463K | 2.09M | 2.55M | 4.72M | 5.41M | 8.62M | 1.12M | 1.37M | 1.14M | 1.14M | 1.14M | 1.14M | 1.27M | 2.67M | 12.32M | 1.49M | 1.42M | n/a |
| Short-Term Debt | 45.78M | 624.4M | 46.94M | 46.76M | 260.78M | 46.12M | 33.39M | 40.6M | 36.09M | 37.59M | 9.43M | 5.57M | 29.69M | n/a | 23.41M | 33.16M | 122.41M | 3.46M | 2.19M | n/a |
| Other Current Liabilities | 896.17M | 774.47M | 787.32M | 650.54M | 338.27M | 255.15M | 264.89M | 198.78M | 193.27M | 164.07M | 173.52M | 175.98M | 104.94M | 46.6M | 32.2M | 21.25M | 33.02M | 29.05M | 21.46M | 18.55M |
| Total Current Liabilities | 1.04B | 1.54B | 933.19M | 809.3M | 653.75M | 364.49M | 345.49M | 293.95M | 257.41M | 226.64M | 216.8M | 204.03M | 191.54M | 52.87M | 59.94M | 59.24M | 173.49M | 36.86M | 30.52M | 23.34M |
| Long-Term Debt | 77.88M | 5.17B | 5.77B | 6.11B | 1.99B | 1.73B | 1.56B | 1.54B | 1.99B | 1.15B | 1.33B | 544.4M | 427.07M | n/a | 24.63M | 91.11M | n/a | 75.12M | 74.28M | 73.63M |
| Other Long-Term Liabilities | 6.13B | 104.75M | 106.81M | 117M | 101.15M | 109.37M | 218.88M | 176.61M | 112.62M | 69.25M | 38.39M | 20.04M | 41.42M | n/a | 11.48M | 19.69M | 25.55M | 28.12M | 286.06M | 186.06M |
| Total Long-Term Liabilities | 6.88B | 6.12B | 6.82B | 7.52B | 2.22B | 2.06B | 2.1B | 2.12B | 2.67B | 1.53B | 1.75B | 738.66M | 653.66M | 7.92M | 45.24M | 120.98M | 36.88M | 115.71M | 360.35M | 259.69M |
| Total Liabilities | 7.92B | 7.66B | 7.75B | 8.33B | 2.88B | 2.43B | 2.45B | 2.41B | 2.92B | 1.76B | 1.97B | 942.69M | 845.2M | 60.78M | 105.18M | 180.23M | 210.38M | 152.56M | 390.87M | 283.03M |
| Total Debt | 69.94M | 5.79B | 5.8B | 6.14B | 2.23B | 1.76B | 1.6B | 1.58B | 2.03B | 1.2B | 1.34B | 549.98M | 456.76M | n/a | 48.04M | 124.27M | 122.41M | 78.58M | 76.47M | 73.63M |
| Common Stock | 6K | 61K | 61K | 61K | 61K | 61K | 61K | 61K | 61K | 61K | 61K | 61K | 61K | 4K | 4K | 3K | 3K | 2K | n/a | n/a |
| Retained Earnings | 1.13B | 878.66M | 733.59M | 830.23M | 1.16B | 1.07B | 841.05M | 917.96M | 528.91M | 302.69M | 34.7M | 18.53M | -61.3M | -349.88M | -474.87M | -507.64M | -500.81M | -316.47M | -177.64M | -118.25M |
| Comprehensive Income | -947.67M | -842.15M | -1.13B | -400.36M | -134.35M | -223.39M | -197.79M | -140.88M | -317.33M | -267.47M | -122.1M | 56.15M | 31.05M | -31K | -6.2M | n/a | 4K | 19K | 12K | 4K |
| Shareholders Equity | 4.09B | 3.74B | 3.09B | 3.97B | 3.66B | 3.11B | 2.76B | 2.71B | 1.88B | 1.6B | 1.37B | 1.3B | 1.12B | 192.79M | 30.55M | -72.83M | -92.88M | 54.99M | -176.3M | -118.25M |
| Total Investments | 580M | 120M | 35.5M | 12.03M | 1.07B | 440M | 515M | 215M | 60M | 23.27M | 33.17M | 14.61M | 16.58M | 75.82M | n/a | n/a | 1M | 12M | n/a | n/a |